Comparative in Silico Analysis of Antigenic Proteins “Nucleocapsid Protein “of SARS-Cov-2 from Different Geographical Locations Volume 2 - Issue 4

Nada M Doleib^1,2*

• ¹Department of Biology, Faculty of Sciences and Arts, University of Jeddah, Saudi Arabia
• ²Department of Microbiology, Faculty of Applied and Industrial Science, University of Bahri, Sudan

Received: March 08, 2021   Published: March 15, 2021

Corresponding author: Nada M Doleib, Department of Biology, Faculty of Sciences and Arts,-Khulais, University of Jeddah, Saudi Arabia

DOI: 10.32474/LOJPCR.2021.02.000141

Fulltext PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

SARS-CoV-2 Nucleocapsid protein considered as a vaccine target. Viral nucleocapsid protein is a potential antiviral drug target, serving multiple critical functions during the viral life cycle. However, the structural information of SARS-CoV-2 in different geographical locations considered as an important factor in order to produce a global vaccine for the pandemic. The present investigation relies on the analysis of the similarities and differences of the SARS-CoV-2 Nucleocapsid protein from various geographical locations, considering certain protein parameters, as well as the study of the alignment of the protein sequence of amino acids.

Keywords: Nucleocapsid protein; SARS-CoV-2; geographical locations; bioinformatics

Abstract| Introduction| Materials and Methods| Results| Discussion| Conclusion| References|